Nucleic Acids Research, 1991, Vol. 19, No. 15 4139-4145
© 1991
MOLECULAR BIOLOGY |
Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region
Department of Biochemistry (M/C 536), University of Illinois College of Medicine 1853 W. Polk St., Chicago, IL 60612, USA 1Fidia-Georgetown Institute for the Neurosciences, Georgetown University Medical School 3900 Reservoir Rd NW, Washington, DC 20007, USA
Received May 1, 1991. Revised July 1, 1991. Accepted July 1, 1991.
The transthyretin (TTR) gene is regulated by two DNA regions which elicit hepatocyte-specific expression: a proximal promoter and distal enhancer. The TTR promoter and enhancer are composed of at least eight DNA binding sites for three different hepatocyte nuclear factors (HNF), CCAAT/enhancer binding protein (C/EBP), and AP-1/cJun. Site directed mutations within each of the HNF binding sites in the TTR promoter were introduced to evaluate their contribution to transcriptional activity in hepatoma cells. The data indicate that the strong affinity HNF3-S binding site (–106 to –94) is absolutely required for TTR promoter activity since several mutations in this site eliminate TTR expression in the context of its enhancer. Conversion of a second weak affinity HNF3-W site (–140 to –131) in the TTR promoter to a high affinity site resulted in higher levels of expression. TTR mutations that disrupted several weak affinity sites (HNF1, HNF3-W, and HNF4) only slightly diminished expression levels in the presence of the TTR enhancer. In contrast, when we deleted the TTR enhancer from these HNF mutant constructs, TTR expression decreased to undetectable levels. This result suggests cooperation between the factors binding to the TTR promoter and enhancer regions. These results also demonstrate that the HNF3-S site alone is not sufficient to activate TTR transcription, but rather requires the participation of three cell-specific factors to elicit minimal promoter activity. The complexity of this promoter design and the requirement for a minimal number of cell-specific factors to achieve transcription allows us to propose a model which may explain the maintenance of tissue-specific expression of TTR.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing Nucleic Acids Res., August 1, 2008; 36(14): 4549 - 4564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tuteja, S. T. Jensen, P. White, and K. H. Kaestner Cis-regulatory modules in the mammalian liver: composition depends on strength of Foxa2 consensus site Nucleic Acids Res., July 1, 2008; 36(12): 4149 - 4157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mody, T. E. Graham, Y. Tsuji, Q. Yang, and B. B. Kahn Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E785 - E793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Viney, T. W. Schmidt, W. Gierasch, A. W. Sattar, R. E. Yaggie, A. Kuburas, J. P. Quinn, J. M. Coulson, and A. F. Russo Regulation of the Cell-specific Calcitonin/Calcitonin Gene-related Peptide Enhancer by USF and the Foxa2 Forkhead Protein J. Biol. Chem., November 26, 2004; 279(48): 49948 - 49955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Long and B. T. Spear FoxA Proteins Regulate H19 Endoderm Enhancer E1 and Exhibit Developmental Changes in Enhancer Binding In Vivo Mol. Cell. Biol., November 1, 2004; 24(21): 9601 - 9609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li and C. D. Klaassen Role of Liver-Enriched Transcription Factors in the Down-Regulation of Organic Anion Transporting Polypeptide 4 (Oatp4; Oatplb2; Slc21a10) by Lipopolysaccharide Mol. Pharmacol., September 1, 2004; 66(3): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Rausa, Y. Tan, and R. H. Costa Association between Hepatocyte Nuclear Factor 6 (HNF-6) and FoxA2 DNA Binding Domains Stimulates FoxA2 Transcriptional Activity but Inhibits HNF-6 DNA Binding Mol. Cell. Biol., January 15, 2003; 23(2): 437 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schrem, J. Klempnauer, and J. Borlak Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression Pharmacol. Rev., March 1, 2002; 54(1): 129 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Costa, V. V. Kalinichenko, and L. Lim Transcription factors in mouse lung development and function Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L823 - L838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakamura, A. Fox-Robichaud, R. Kikkawa, A. Kashiwagi, H. Kojima, M. Fujimiya, and N. C. W. Wong Transcription factors and age-related decline in apolipoprotein A-I expression J. Lipid Res., September 1, 1999; 40(9): 1709 - 1718. [Abstract] [Full Text]
|
|
|
|
|
|
H. Skala, A. Porteu, M. Thomas, M.-F. Szajnert, H. Okazawa, A. Kahn, and F. Phan-Dinh-Tuy Upstream Elements Involved in Vivo in Activation of the Brain-specific Rat Aldolase C Gene. ROLE OF BINDING SITES FOR POU AND WINGED HELIX PROTEINS J. Biol. Chem., November 27, 1998; 273(48): 31806 - 31814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Bowman, H Symonds, L Gu, C Yin, M Oren, and T Van Dyke Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes & Dev., April 1, 1996; 10(7): 826 - 835. [Abstract] [PDF]
|
|
|
|
|
|
M. Thomas, H. Skala, A. Kahn, and F.ço. P. D. Tuy Functional Dissection of the Brain-specific Rat Aldolase C Gene Promoter in Transgenic Mice J. Biol. Chem., September 1, 1995; 270(35): 20316 - 20321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Angrand, J. P. Rousset, and M. C. Weiss Cell phenotype, binding affinity and promoter structure modulate transactivation by HNF1 and LAP J. Cell Sci., December 1, 1992; 103(4): 1083 - 1092. [Abstract] [PDF]
|
|